32 results
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
13 Nov 23
Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:15am
. Lee. “This oral potent antiviral candidate could reduce severity and death from pandemic outbreaks of highly contagious viral infections. CDI-988 has
8-K
EX-3.1
COCP
Cocrystal Pharma Inc
19 Feb 21
Amendments to Articles of Incorporation or Bylaws
8:30am
not be revoked by the incompetence or death of the stockholder who executed the proxy unless, before the authority is exercised, written notice … of an adjudication of such incompetence or of such death is received by the corporate officer responsible for maintaining the list of stockholders.
If a proxy
8-K
EX-10.1
j2l9cn7og
11 Mar 19
Cocrystal Pharma Announces Closing of Private Placement
8:35am
S-8
EX-10.1
i1opb u7c0y
11 May 18
Registration of securities for employees
4:16pm
8-K
EX-3.4
hlm6 s7wy36fxs2du
1 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
ke6i 9fzblaxizqcdi
1 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.6
ttmarwayd8bgyydg2740
1 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
df1b8jt0 p9jycjvrg0c
8 Jan 14
Completion of Acquisition or Disposition of Assets
12:00am